1q21 Gain Combined with High‐Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in China

BACKGROUND. The prognostic value of 1q21 gain in newly diagnosed multiple myeloma (NDMM) remains controversial. Our aim was to investigate the prognostic value of 1q21 gain in a Chinese population. MATERIALS AND METHODS. We retrospectively identified 565 patients with NDMM from multiple centers in C...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaozhe, Chen, Wenming, Wu, Yin, Li, Jianyong, Chen, Lijuan, Fang, Baijun, Feng, Ying, Liu, Junru, Chen, Meilan, Gu, Jingli, Huang, Beihui, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Hematologic Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853115/
https://www.ncbi.nlm.nih.gov/pubmed/31455749
http://dx.doi.org/10.1634/theoncologist.2019-0132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853115/
https://www.ncbi.nlm.nih.gov/pubmed/31455749
http://dx.doi.org/10.1634/theoncologist.2019-0132

Ejemplares similares